Thakker Parth Udayan, O'Rourke Timothy Kirk, Hemal Ashok Kumar
Department of Urology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Department of Urology, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Transl Androl Urol. 2023 Jul 31;12(7):1184-1198. doi: 10.21037/tau-23-107. Epub 2023 Jul 17.
Nephron sparing surgery (NSS) is the preferred management for clinical stage T1 (cT1) renal masses. In recent years, indications have expanded to larger and more complex renal tumors. In an effort to provide optimal patient outcomes, urologists strive to achieve the pentafecta when performing partial nephrectomy. This has led to the continuous technologic advancement and technique refinement including the use of augmented reality, ultrasound techniques, changes in surgical approach and reconstruction, uses of novel fluorescence marker guided imaging, and implementation of early recovery after surgery (ERAS) protocols. The aim of this narrative review is to provide an overview of the recent advances in pre-, intra-, and post-operative management and approaches to managing patients with renal masses undergoing NSS.
We performed a non-systematic literature search of PubMed and MEDLINE for the most relevant articles pertaining to the outlined topics from 2010 to 2022 without limitation on study design. We included only full-text English articles published in peer-reviewed journals.
Partial nephrectomy is currently prioritized for cT1a renal masses; however, indications have been expanding due to a greater understanding of anatomy and technologic advances. Recent studies have demonstrated that improvements in imaging techniques utilizing cross-sectional imaging with three-dimensional (3D) reconstruction, use of color doppler intraoperative ultrasound, and newer studies emerging using contrast enhanced ultrasound play important roles in certain subsets of patients. While indocyanine green administration is commonly used, novel fluorescence-guided imaging including folate receptor-targeting fluorescence molecules are being investigated to better delineate tumor-parenchyma margins. Augmented reality has a developing role in patient and surgical trainee education. While pre-and intra-operative imaging have shown to be promising, near infrared guided segmental and sub-segmental vessel clamping has yet to show significant benefit in patient outcomes. Studies regarding reconstructive techniques and replacement of reconstruction with sealing agents have a promising future. Finally, ERAS protocols have allowed earlier discharge of patients without increasing complications while improving cost burden.
Advances in NSS have ranged from pre-operative imaging techniques to ERAS protocols Further prospective investigations are required to determine the impact of novel imaging, fluorescence biomarker use, and reconstructive techniques on achieving the pentafecta of NSS.
保留肾单位手术(NSS)是临床T1期(cT1)肾肿瘤的首选治疗方法。近年来,其适应证已扩展至更大、更复杂的肾肿瘤。为了给患者带来最佳治疗效果,泌尿外科医生在进行部分肾切除术时力求实现“五连胜”。这促使技术不断进步和术式不断完善,包括使用增强现实、超声技术、手术入路和重建方式的改变、新型荧光标记引导成像的应用以及实施术后早期恢复(ERAS)方案。本叙述性综述的目的是概述肾肿瘤患者接受NSS治疗时术前、术中和术后管理及治疗方法的最新进展。
我们对PubMed和MEDLINE进行了非系统性文献检索,以查找2010年至2022年与上述主题最相关的文章,对研究设计无限制。我们仅纳入发表在同行评审期刊上的全文英文文章。
目前,cT1a期肾肿瘤优先选择部分肾切除术;然而,由于对解剖结构的深入理解和技术进步,其适应证一直在扩大。近期研究表明,利用三维(3D)重建的断层成像、术中彩色多普勒超声以及使用对比增强超声的新研究等成像技术的改进,在某些患者亚组中发挥着重要作用。虽然吲哚菁绿给药常用,但包括叶酸受体靶向荧光分子在内的新型荧光引导成像正在研究中,以更好地勾勒肿瘤-实质边界。增强现实在患者和外科实习医生教育方面的作用正在发展。虽然术前和术中成像已显示出前景,但近红外引导的节段性和亚节段性血管夹闭在患者治疗效果方面尚未显示出显著益处。关于重建技术以及用封闭剂替代重建的研究前景广阔。最后,ERAS方案使患者能够更早出院,且不增加并发症,同时减轻了成本负担。
NSS的进展涵盖了从术前成像技术到ERAS方案等多个方面。需要进一步的前瞻性研究来确定新型成像、荧光生物标志物的使用以及重建技术对实现NSS“五连胜”的影响。